2019 annual financial data
Neuphoria Therapeutics 2019 Operating margin
Direct answer
Operating margin was -145.46%.
Operating income was -10,756,597 USD and net income was -6,771,657 USD.
Operating cash flow was -10,912,614 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,395,069 USD
- Operating income
- -10,756,597 USD
- Net income
- -6,771,657 USD
- Operating cash flow
- -10,912,614 USD